New pill aims to tame rare inflammatory disease
NCT ID NCT07190196
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 4 times
Summary
This phase 3 study tests whether the oral drug rilzabrutinib can prevent disease flares in adults with active IgG4-related disease, a rare condition causing swelling and organ damage. About 124 participants will receive either rilzabrutinib or a placebo for 52 weeks, alongside standard glucocorticoids. The main goal is to see how long it takes for a flare to occur, and whether the drug helps reduce steroid use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- rilzabrutinib (a tablet taken by mouth)
- What this could lead to
- If it works, this could offer a new treatment option to control IgG4-related disease and reduce the need for steroids.
- What could go wrong
- This is a phase 3 trial, but it's still experimental. The drug may not work better than placebo, and side effects are possible. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGG4-RELATED DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
AOU Meyer IRCCS-Site Number : 3800003
RECRUITINGFlorence, Firenze, 50139, Italy
-
AP-HP - Hôpital Beaujon-Site Number : 2500002
ACTIVE_NOT_RECRUITINGClichy, 92110, France
-
CHU Bordeaux - Hôpital Haut Leveque-Site Number : 2500003
ACTIVE_NOT_RECRUITINGPessac, 33600, France
-
Centro Ricerche Cliniche di Verona s.r.l. c/o Policlinico G.B.Rossi-Site Number : 3800002
RECRUITINGVerona, Veneto, 37134, Italy
-
Centro de estudios G y C-Site Number : 1520003
RECRUITINGSantiago, Reg Metropolitana de Santiago, 7500504, Chile
-
Cleveland Clinic - Cleveland- Site Number : 8400001
RECRUITINGCleveland, Ohio, 44195, United States
-
Digestive Health Research of North Texas- Site Number : 8400021
RECRUITINGWichita Falls, Texas, 76301, United States
-
Emory University School of Medicine - Atlanta- Site Number : 8400013
RECRUITINGAtlanta, Georgia, 30322, United States
-
Epic Medical Research - Red Oak- Site Number : 8400003
RECRUITINGRed Oak, Texas, 75154, United States
-
Erasmus Medisch Centrum-Site Number : 5280001
ACTIVE_NOT_RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
-
Hiroshima University Hospital-Site Number : 3920007
RECRUITINGHiroshima, Hiroshima, 734-8551, Japan
-
IRCCS Ospedale San Raffaele-Site Number : 3800001
RECRUITINGMilan, Lombardy, 20132, Italy
-
Investigational Site Number : 0320002
RECRUITINGResistencia, Chaco Province, 3500, Argentina
-
Investigational Site Number : 0320003
RECRUITINGSan Isidro, Buenos Aires, B1643CRO, Argentina
-
Investigational Site Number : 0320004
RECRUITINGBuenos Aires, 1015, Argentina
-
Investigational Site Number : 0320005
RECRUITINGBerazategui, Buenos Aires, 1886, Argentina
-
Investigational Site Number : 0560001
RECRUITINGLeuven, 3000, Belgium
-
Investigational Site Number : 1240001
RECRUITINGSherbrooke, Quebec, J1G 2E8, Canada
-
Investigational Site Number : 1520001
RECRUITINGSantiago, Reg Metropolitana de Santiago, 8320325, Chile
-
Investigational Site Number : 1520002
RECRUITINGSantiago, Reg Metropolitana de Santiago, 8330032, Chile
-
Investigational Site Number : 1520005
RECRUITINGConcepción, Biobio, 4070038, Chile
-
Investigational Site Number : 1520006
RECRUITINGSantiago, Reg Metropolitana de Santiago, 8207257, Chile
-
Investigational Site Number : 1560001
RECRUITINGBeijing, 100730, China
-
Investigational Site Number : 1560003
RECRUITINGJiazhuang, 050000, China
-
Investigational Site Number : 1560004
RECRUITINGBeijing, 100050, China
-
Investigational Site Number : 1560005
RECRUITINGTaiyuan, 030032, China
-
Investigational Site Number : 1560008
RECRUITINGBeijing, 100034, China
-
Investigational Site Number : 1560009
RECRUITINGYantai, 264001, China
-
Investigational Site Number : 1560010
RECRUITINGHangzhou, 310009, China
-
Investigational Site Number : 1560011
RECRUITINGWuhan, 430030, China
-
Investigational Site Number : 1560012
RECRUITINGChengdu, 610041, China
-
Investigational Site Number : 1560013
RECRUITINGTaiyuan, 030001, China
-
Investigational Site Number : 1580001
RECRUITINGTaipei, 10016, Taiwan
-
Investigational Site Number : 1580002
RECRUITINGTaoyuan City, 333, Taiwan
-
Investigational Site Number : 1580004
RECRUITINGKaohsiung City, 833, Taiwan
-
Investigational Site Number : 2500001
RECRUITINGMarseille, 13885, France
-
Investigational Site Number : 2760001
RECRUITINGBerlin, 13353, Germany
-
Investigational Site Number : 2760003
RECRUITINGErlangen, 91054, Germany
-
Investigational Site Number : 2760004
RECRUITINGMinden, 32429, Germany
-
Investigational Site Number : 2760006
RECRUITINGUlm, 89081, Germany
-
Investigational Site Number : 3920001
RECRUITINGKanazawa, Ishikawa-ken, 920-8641, Japan
-
Investigational Site Number : 3920003
RECRUITINGHirakata, Osaka, 573-1191, Japan
-
Investigational Site Number : 3920004
RECRUITINGKitakyushu, Fukuoka, 807-8555, Japan
-
Investigational Site Number : 3920005
RECRUITINGNagaoka, Niigata, 940-2085, Japan
-
Investigational Site Number : 3920008
RECRUITINGBunkyo-ku, Tokyo, 113-8677, Japan
-
Investigational Site Number : 3920009
RECRUITINGTokyo, 160-8582, Japan
-
Investigational Site Number : 3920011
RECRUITINGSapporo, Hokkaido, 060-8543, Japan
-
Investigational Site Number : 4100001
RECRUITINGSeoul, Seoul-teukbyeolsi, 03080, South Korea
-
Investigational Site Number : 4100002
RECRUITINGSuwon, Gyeonggi-do, 16499, South Korea
-
Investigational Site Number : 6160002
RECRUITINGWroclaw, Lower Silesian Voivodeship, 50-556, Poland
-
Investigational Site Number : 6820001
RECRUITINGRiyadh, 12713, Saudi Arabia
-
Investigational Site Number : 6820002
RECRUITINGRiyadh, 12372, Saudi Arabia
-
Investigational Site Number : 7240001
RECRUITINGBarcelona, Barcelona [Barcelona], 08035, Spain
-
Investigational Site Number : 7240002
RECRUITINGBarcelona, Catalunya [Cataluña], 08041, Spain
-
Investigational Site Number : 7240004
RECRUITINGMadrid, 28034, Spain
-
Investigational Site Number : 7520001
RECRUITINGHuddinge, 141 57, Sweden
-
Investigational Site Number : 7520002
RECRUITINGUppsala, 751 85, Sweden
-
Investigational Site Number : 8260004
RECRUITINGNorwich, Norfolk, NR4 7UY, United Kingdom
-
Kaiser Permanente - Fontana Medical Center- Site Number : 8400015
RECRUITINGFontana, California, 92335, United States
-
Kanazawa Medical University Hospital-Site Number : 3920002
RECRUITINGKahoku, Uchinada, Ishikawa-ken, 920-0293, Japan
-
Kobe University Hospital-Site Number : 3920010
RECRUITINGKobe, Hyōgo, 650-0017, Japan
-
Life Clinical Trials - Margate - Colonial Drive- Site Number : 8400002
RECRUITINGMargate, Florida, 33063, United States
-
Malopolskie Badania Kliniczne sp. z. o.o.-Site Number : 6160001
RECRUITINGKrakow, Lesser Poland Voivodeship, 30-002, Poland
-
Massachusetts General Hospital- Site Number : 8400008
RECRUITINGBoston, Massachusetts, 02114, United States
-
Mayo Clinic in Rochester - Minnesota- Site Number : 8400017
RECRUITINGRochester, Minnesota, 55905, United States
-
Ohio State University Wexner Medical Center- Site Number : 8400024
RECRUITINGColumbus, Ohio, 43215, United States
-
Paramount Medical Research and Consulting LLC- Site Number : 8400018
RECRUITINGMiddleburg Heights, Ohio, 44140, United States
-
Primeway Clinical Research- Site Number : 8400019
RECRUITINGFayetteville, Georgia, 30214, United States
-
Rabin MC, Outpatient Clinics Building-Site Number : 3760001
RECRUITINGPetah Tikva, Central District, 4941492, Israel
-
San Jose Clinical Trials- Site Number : 8400016
RECRUITINGSan Jose, California, 95128, United States
-
Schiff Center for Liver Diseases- Site Number : 8400010
RECRUITINGMiami, Florida, 33136, United States
-
Solace Clinical Research - Tustin- Site Number : 8400020
RECRUITINGTustin, California, 92780, United States
-
Sourasky Rheumatology Dept, Rishonim Building-Site Number : 3760005
RECRUITINGTel Aviv, Central District, 6423906, Israel
-
Stryde Research- Site Number : 8400011
RECRUITINGPlano, Texas, 75093, United States
-
The Institute of Medical Science, The University of Tokyo-Site Number : 3920006
RECRUITINGMinato-ku, Tokyo, 108-8639, Japan
-
UMCG-Site Number : 5280002
ACTIVE_NOT_RECRUITINGGroningen, 9713 GZ, Netherlands
-
Uniwersyteckie Centrum Kliniczne, Centrum Wsparcia Badan Klinicznych UCK Osrodek Badan Wczesnych Faz-Site Number : 6160003
RECRUITINGGdansk, Pomeranian Voivodeship, 80-214, Poland
-
Velocity Clinical Research - Seattle- Site Number : 8400005
RECRUITINGSeattle, Washington, 98105, United States
-
Vitalia Medical Research - Margate- Site Number : 8400025
RECRUITINGPalm Beach Gardens, Florida, 33410, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A steroid-sparing strategy for IgG4-related disease: lenalidomide put to the test
- New drug aims to stop IgG4 disease relapses without Long-Term steroids
- Experimental CAR-T injection aims to tame autoimmune diseases
- Scientists investigate immune cell role in rare IgG4 disease
- Old drug, new hope: could filgotinib tame rare immune diseases?
- New scan could shine a light on hidden inflammation